Prostate adenocarcinoma, Gleason 7 (3+4)

Abdomen / Genitourinary· Published 22 Oct 2026· 4 images· 2 min read

Written and reviewed by RadLearn editorial team · Updated 22 Oct 2026

Figures (4)

Figure 1 of 4
Axial ADC map showing restricted diffusion in the prostate.
Figure 1. Axial ADC map showing restricted diffusion in the prostate.
Click the image to enlarge. Use the list to switch figures. 1 / 4

Patient history

History: Patient with benign prostatic hypertrophy, rising PSA now >12 ng/mL and urinary tract obstruction. Previous colectomy for ulcerative colitis of the colon; the rectum is absent. Imaging work-up included multiparametric MRI and CT.

Imaging findings — key points

  • Rising PSA >12 ng/mL with urinary tract obstruction raises suspicion of prostate cancer.
  • Diffusion-weighted imaging (ADC map) is key for detecting restricted diffusion in prostate tumours.
  • Perfusion imaging (DCE) adds functional information for tumour characterisation.
  • Axial T2-weighted imaging provides anatomical detail of the prostate and seminal vesicles.
  • Post-contrast T1-weighted SPGR helps assess enhancement patterns.
  • CT guidance is used for targeted biopsy; the absent rectum alters the approach.
Final diagnosis: Prostate adenocarcinoma, Gleason 7 (3+4), on a background of benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatitis.

Discussion

This case illustrates the multiparametric MRI work-up of suspected prostate cancer in a patient with rising PSA and urinary obstruction. The ADC map and perfusion imaging are central to identifying and characterising focal prostatic lesions, while T2-weighted and post-contrast T1-weighted images provide anatomical and enhancement information. A key pitfall is the absent rectum following colectomy for ulcerative colitis of the colon, which alters the usual endorectal or transrectal biopsy approach and may affect image quality. Computer-aided detection (CAD) and CT-guided biopsy were used to target the lesion. The final histology confirmed prostate adenocarcinoma, Gleason 7 (3+4), alongside benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatitis. Management implication: accurate Gleason grading guides prognosis and treatment selection.

Differential diagnosis

Alternative diagnosisKey features that distinguish it from this case
Benign prostatic hypertrophyEnlarged prostate with transitional zone nodules; usually no marked restricted diffusion or early enhancement.
ProstatitisDiffuse or patchy signal change, often with clinical infection; may show restricted diffusion but usually less focal.
Prostatic intraepithelial neoplasiaHistological diagnosis; imaging may be normal or show subtle changes, not a discrete mass.
Prostate adenocarcinomaFocal lesion with restricted diffusion and early enhancement; confirmed by biopsy.

The confirmed diagnosis itself is not included as an alternative — it is stated separately below.

See all Abdomen differential diagnoses